期刊文献+

ImmunoCytTM and cytology for diagnosis of bladder carcinoma:a meta analysis 被引量:3

ImmunoCytTM and cytology for diagnosis of bladder carcinoma:a meta analysis
原文传递
导出
摘要 Background Currently,cystoscopy and urine cytology are standard modalities in therapy monitoring and follow-up of bladder carcinoma (BC).Cystoscopy is an invasive and uncomfortable procedure while cytology has a limited value because it is operator-dependent and has low sensitivity.This study was to assess the accuracy of ImmunoCyt in detecting BC by comparing it with cytology using systemic analyses of studies published in both English and Chinese.Methods Cochrane systematic evaluation was used to search through MEDLINE,EMBASE,Cochrane Library,CMCC,and CNKI for studies regarding ImmunoCyt and cytology for detection of BC.Data were extracted and analyzed by the software MetaDiSc 1.4.Results In total 42 relevant studies were searched,of which 15 were enrolled and 12 491 patients were included.Heterogeneity,except for threshold effects,was found within these studies.A meta-analysis was performed using the random effect model.Pooled accuracy indicators like sensitivity,specificity,and diagnostic odds ratio of ImmunoCytTM and cytology were 0.75 (0.73-0.77) vs.0.45 (0.43-0.48),0.73 (0.72-0.74) vs.0.97 (0.96-0.97),and 10.97 (7.53-15.99) vs.16.40 (10.57-25.46),respectively.The sensitivity of both was increased with the increase of tumor grade and stage.The area under summary receiver operating characteristics curve was 0.834 4 and 0.853 4 and the Q index 0.766 7 and 0.785 3 for ImmunoCyt and cytology,respectively.Combination of both can obviously improve the accuracy of diagnosis.Conclusions ImmunoCyt has a high sensitivity in detecting BC,but its specificity is low.As an important adjunct,ImmunoCytTM can not replace cytology,but combined with cytology it could improve sensitivity with high specificity in the detection and postoperative monitoring of BC. Background Currently,cystoscopy and urine cytology are standard modalities in therapy monitoring and follow-up of bladder carcinoma (BC).Cystoscopy is an invasive and uncomfortable procedure while cytology has a limited value because it is operator-dependent and has low sensitivity.This study was to assess the accuracy of ImmunoCyt in detecting BC by comparing it with cytology using systemic analyses of studies published in both English and Chinese.Methods Cochrane systematic evaluation was used to search through MEDLINE,EMBASE,Cochrane Library,CMCC,and CNKI for studies regarding ImmunoCyt and cytology for detection of BC.Data were extracted and analyzed by the software MetaDiSc 1.4.Results In total 42 relevant studies were searched,of which 15 were enrolled and 12 491 patients were included.Heterogeneity,except for threshold effects,was found within these studies.A meta-analysis was performed using the random effect model.Pooled accuracy indicators like sensitivity,specificity,and diagnostic odds ratio of ImmunoCytTM and cytology were 0.75 (0.73-0.77) vs.0.45 (0.43-0.48),0.73 (0.72-0.74) vs.0.97 (0.96-0.97),and 10.97 (7.53-15.99) vs.16.40 (10.57-25.46),respectively.The sensitivity of both was increased with the increase of tumor grade and stage.The area under summary receiver operating characteristics curve was 0.834 4 and 0.853 4 and the Q index 0.766 7 and 0.785 3 for ImmunoCyt and cytology,respectively.Combination of both can obviously improve the accuracy of diagnosis.Conclusions ImmunoCyt has a high sensitivity in detecting BC,but its specificity is low.As an important adjunct,ImmunoCytTM can not replace cytology,but combined with cytology it could improve sensitivity with high specificity in the detection and postoperative monitoring of BC.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第4期758-764,共7页 中华医学杂志(英文版)
关键词 bladder carcinoma ImmunoCytTM CYTOLOGY bladder carcinoma ImmunoCytTM cytology
  • 相关文献

参考文献26

  • 1Lee R,Droller MJ. The natural history of bladder cancer Implications for therapy[J].{H}Urologic Clinics of North America,2000.1-13.
  • 2Dalbagni G,Herr HW. Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer[J].{H}Urologic Clinics of North America,2000.137-146.
  • 3Schroeder GL,Lorenzo-Gomez MF,Hautmann SH,Friedrich MG Ekici S Huland H. A side by side comparison of cytology and biomarkers for bladder cancer detection[J].{H}Journal Of Urology,2004.1123-1126.
  • 4Fradet Y,Lockhard C. Performance characteristics of a new monoclonal antibody test for bladder cancer:ImmunoCyt trade mark[J].{H}Canadian journal of urology(the),1997.400-405.
  • 5Whiting P,Rutjes AW,Reitsma JB,Bossuyt PM,Kleijnen J. The development of QUADAS:a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews[J].{H}BMC Medical Research Methodology,2003.25.
  • 6Jadad AR,Moore RA,Carroll D,Jenkinson C,Reynolds D J,Gavaghan D J. Assessing the quality of reports of randomized clinical trials:is blinding necessary[J].{H}Controlled Clinical Trials,1996.1-12.
  • 7Comploj E,Mian C,Ambrosini-Spaltro A,Dechet C,Palermo S,Trenti E. uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma:an update on 7422 analyses[J].{H}CANCER CYTOPATHOLOGY,2013.392-397.
  • 8Li HX,Li M,Li CL,Ma JH,Wang MR,Rao J. ImmunoCyt and cytokeratin,20 immunocytochemistry as adjunct markers for urine cytologic detection of bladder cancer:a prospective study[J].Anal Quant Cytol Histo1,2010.45-52.
  • 9Horstmann M,Patschan O,Hennenlotter J,Senger E Feil G Stenzl A. Combinations of urine-based tumour markers in bladder cancer surveillance[J].{H}SCANDINAVIAN Journal OF UROLOGY AND NEPHROLOGY,2009.461-466.
  • 10Soyuer I,Sofikerim M,Tokat F,Soyuer S,Ozturk F. Which urine marker test provides more diagnostic value in conjunction with standard cytology-ImmunoCyt/uCyt+ or Cytokeratin,20 expression[J].{H}Diagnostic Pathology,2009.20.

同被引文献14

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部